Latest "North Coast Clinical Laboratory Incorporated" News Stories

12:16 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "North Coast Clinical Laboratory Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about North Coast Clinical Laboratory Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about North Coast Clinical Laboratory Incorporated for you to read. Along with our medical data and news we also list North Coast Clinical Laboratory Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of North Coast Clinical Laboratory Incorporated Companies for you to search.

Showing "North Coast Clinical Laboratory Incorporated" News Articles 1–25 of 21,000+

Thursday 21st March 2019

Rex Medical completes patient enrollment in REVEAL IDE clinical trial

Rex Medical stated that the trial is a single arm, prospective study to assess the safety and efficacy of the Revolution Peripheral Atherectomy System in treating infrainguinal lower The post Rex Medical completes patient enrollment in REVEAL IDE clinical trial appeared first on Compelo Medical Devices - Latest industry news and analysis.

Pharmacy Development Services (PDS) Announces Travis Wolff of Med-World Pharmacy as 2018 Pharmacist of the Year

2018 Pharmacist of the Year Named ORLANDO, Fla. (PRWEB) March 21, 2019 Travis Wolff, owner of Med-World Pharmacy, has been named 2018 Pharmacist of the Year by Pharmacy Development Services. PDS named the 2018 award winner at the 15th annual PDS Super-Conference ( The Pharmacist of the Year award is given annually and honors one pharmacy owner’s dedication to impr...

City of Hope Scientists Showcase New Findings at the 2019 AACR Meeting

Researchers will discuss data and ongoing studies involving CAR T cell therapy, advanced nonsmall cell lung cancer, use of natural compounds and health equity. City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immuno...

PersonalMed Appoints Veteran Pharmacy Executive, Bill Letendre, MSPharm, MBA, as President

PersonalMed, LLC, today announced board member Bill Letendre, MSPharm, MBA, has been named president, effective immediately. As president, Letendre will have responsibility for all of the company's operations. He will report directly to the board. This press release features multimedia. View the full release here:

Pharmacists with additional skills can take 'overall clinical responsibility' for patients in A&E, study finds

Pharmacists with additional clinical skills training can take clinical responsibility for patients in hospital emergency departments, according to research published in the International Journal of Clinical Pharmacy.


DGAP-News: Evotec AG / Key word(s): Miscellaneous 21.03.2019 / 14:26 The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 21 March 2019: Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report its financial results for 2018 on Thursday, 28 March 2019. The Company is going to hold a conference call to discuss the results...

Cardiovascular, renal and metabolic (#CVRM) patients often have overlapping diseases and associated risk factors. At AstraZeneca, we continually evolve our clinical research with a goal to help advance clinical practice for preventive therapies for these

Cardiovascular, renal and metabolic ( #CVRM) patients often have overlapping diseases and associated risk factors. At AstraZeneca, we continually evolve our clinical research with a goal to help advance clinical practice for preventive therapies for these patients.

OncLive® Announces Ed Kim as Program Chair for Inaugural Global Expo

The three-day meeting will provide educational opportunities in all areas of oncology. OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, announced Edward Kim, MD, FACP, a clinical oncology expert, as the program chai...

Fish-Inspired Material Changes Color Using Nanocolumns

NewsInspired by the flashing colors of the neon tetra fish, researchers have developed a technique for changing the color of a material by manipulating the orientation of nanostructured columns in the material.

Cofactor Genomics to Present on Predictive Immune Modeling at 2019 American Association for Cancer Research Annual Meeting

-- Presenting early data in collaboration with TriStar Technology Group -- Cofactor Genomics today announced that Natalie LaFranzo, the company’s Director of Scientific Projects and Market Development, will present at the 2019 Annual Meeting of the American Association for Cancer Research (AACR) being held at the Georgia World Congress Center in Atla...

ValiRx boss “delighted” with progress of cancer drug VAL201 and VAL301 for endometriosis

VAL201 is coming towards the end of a Phase I/II study, while VAL301 is in late pre-clinical development

Novel Drug Targets Stem Cell Activity in Pancreatic Cancer

Napabucasin, a novel therapy that targets cancer stem cell pathways, is being investigated in a phase III clinical trial that is believed to be the largest study ever conducted in pancreatic ductal adenocarcinoma in the metastatic setting

Auris Medical Holding (EARS) - Full-year results and near-term trial initiations

Edison Investment Research - Pharmaceuticals & healthcare - Auris Medical Holding: Auris recently announced its full-year 2018 financial results and provided an update on its active intranasal betahistine programs. R&D expenditure for the year was down roughly 65% compared to FY17, which reflects the shift to focus on earlier-stage program development. Auris plans to initiate the AM-125 Phase ...

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development

Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and deve...

Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds

Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier...

Biogen just halted a major clinical trial for an Alzheimer's drug. For more, read @sxbeagle on why the pipeline for these drugs is so pathetic. 

Biogen just halted a major clinical trial for an Alzheimer's drug. For more, read @sxbeagle on why the pipeline for these drugs is so pathetic. 

HMP Announces Lineup of Psych Congress Regionals for 2019

Regional meeting series will deliver enhanced mental health education in eight cities across the country MALVERN, Pa. (PRWEB) March 21, 2019 As part of an ongoing and focused effort to improve the state of mental health care by equipping clinicians with practical education, HMP, a leader in healthcare events and education, today announced the 2019 locations and program highlights for its lineup o...

Detecting Arrhythmias in Clinical Trials Using ECG Monitoring, New Webinar Hosted by Xtalks

Clinical trials in cardiovascular medicine have grown in size, scope and complexity, requiring instruments for monitoring the heart to keep pace. Electrocardiographic (ECG) monitoring has evolved from simple heart rate and basic rhythm determination to the diagnosis of complex arrhythmias and other conditions. In this free webinar, learn how event and continuous ECG monitoring plays a role in clin...

uBiome Awards Grant to The Australian National University to Study the Association Between Personality Disorders and the Gut Microbiome

The leader in microbial genomics awards grant to team of researchers at The Australian National University to investigate the relationship between mental illness and the gut microbiome. SAN FRANCISCO (PRWEB) March 21, 2019 uBiome, the leader in microbial genomics, has awarded microbiome research support in study design, planning, sample collection, and analysis to researchers at The Australian Na...

OSP Unveils AI-Driven Custom Healthcare Software Solutions

With strict government regulations, value-based care needs, rising patient safety expectations, and demand for lower healthcare costs, the global healthcare industry is facing tremendous pressure to take the help of healthcare automation and AI-based solutions. These solutions can help to streamline healthcare processes resulting in rendering cost-effective healthcare services with enhanced effici...

Ligand to Receive Milestone and Royalties as Result of FDA Approval of Sage Therapeutics’ ZULRESSO™ (brexanolone) Injection

ZULRESSO is the first and only treatment specifically indicated for postpartum depression Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it will receive a $3 million milestone payment as a result of the U.S. Food and Drug Administration’s (FDA) approval of Sage Therapeutics’ (NASDAQ: SAGE) ZULRESSOTM (brexanolone) injection for t...

ROTH Capital Partners to Host ROTH Battle of the NASH Thrones Spring Investor Conference in New York City on March 28th, 2019

Event to Feature One-on-One Meetings Between Institutional Investors and Senior Management Teams Representing Companies Focused on NASH, as well as five panel discussions on several key topics at the current forefront of NASH drug development. ROTH Capital Partners (ROTH),, a full service investment bank focused on serving emergi...

Option Care ASPEN Study Shows Clinical Interventions in Home Nutrition Patients Reduce Readmissions, Save Costs

Clinical interventions provided by a nutrition support team can prevent hospital readmission in patients with short bowel syndrome (SBS) receiving home parenteral nutrition (PN), saving millions in costs annually, suggests a study¹ by Option Care Enterprises, Inc. (“Option Care”), the nation’s leading provider of home and alternate site infusion the...

Biologics by McKesson Expands Specialty Pharmacy Capabilities to Serve Patients with Rare and Complex Conditions

Exclusive distribution agreement for rare disease therapy strengthens the specialty pharmacy’s footprint beyond oncology Biologics by McKesson continues to expand its capabilities as a specialty pharmacy expert in oncology and complex conditions through a new exclusive distribution agreement. After making recent investments

Ovarian cancer drug niraparib maintains remission and extends time without symptoms

Findings from a recent clinical trial presented today at the Society of Gynecologic Oncology’s 50th Annual Meeting on Women’s Cancer revealed that women with recurrent ovarian cancer who received niraparib as maintenance therapy experienced more time...

Quick Search


News Quicklinks